Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled glutathione versus placebo in cystic fibrosis
2008-005080-33Phase 3Active
- Sponsor
- Monaldi Hospital
- Start
- Jan 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in cystic fibrosis (CF) comparing Inhaled glutathione with Placebo (2 arms). Primary endpoint: FEV1 response. Started Jan 2009; status: active.
02
Drugs
glutathione
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2008-005080-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005080-33.